Doctor profile · Federal record
Dr. Wendy Stock
Hematology & Oncology Physician (CMS: Hematopoietic Cell Transplantation and Cellular Therapy) · Chicago, IL
- NPI 1588727093
- Accepts Medicare
- MIPS 87.7 / 100 · 2023
- 41 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5841 S Maryland Ave
Chicago, IL 606371443
(888) 824-0200 - Mailing address
-
150 Harvester Dr, Suite 300
Burr Ridge, IL 605275919
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- October 24, 2022
- Year of graduation
- 1985 — 41 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Illinois #036075340
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588727093. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
285
Distinct HCPCS
4
Medicare allowed
$33,825
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 115 | 28 | $125 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 70 | 42 | $102 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 67 | 34 | $150 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 33 | 21 | $69 |
In context: peer comparison
Among 77 peers in Chicago Hematology & Oncology Physician, average services per provider: 870. This provider delivers 0.3× the peer median.Open Payments
Industry payments received
All-time total
$5,339
Transactions
5
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Servier Affaires Medicales | 1 | $2,720.00 | |
| Adaptive Biotechnologies Corporation | 3 | $2,545.76 | |
| Jazz Pharmaceuticals INC. | 1 | $73.49 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
128
Patients
0
Total drug cost
$1,557,907
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Venclexta (Venetoclax) | Brand | 36 | 0 | $529,296 |
| Calquence (Acalabrutinib Maleate) | Brand | 35 | 0 | $551,129 |
| Acyclovir | Generic | 24 | 0 | $494 |
| Tasigna (Nilotinib Hcl) | Brand | 18 | 0 | $170,567 |
| Iclusig (Ponatinib Hcl) | Brand | 15 | 0 | $306,420 |
Frequently asked questions
What is Dr. Wendy Stock's medical specialty?
Dr. Wendy Stock practices Hematology & Oncology Physician in Chicago, IL.
Where does Dr. Wendy Stock practice?
Dr. Wendy Stock practices at 5841 S Maryland Ave, Chicago, IL 606371443. Office phone: 8888240200.
What is Dr. Wendy Stock's NPI?
Dr. Wendy Stock's National Provider Identifier (NPI) is 1588727093, issued by NPPES.
Does Dr. Wendy Stock accept Medicare assignment?
Yes. Dr. Wendy Stock accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Wendy Stock commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.